CKD-510, A Non-hydroxamic Acid Hdac6 Inhibitor, For Treatment Of Atrial Fibrillation.
Event: ESC Congress 2022
Topic: Antiarrhythmic Pharmacotherapy
Session: Basic and Translational Late-Breaking Science 2
ESC 365 is supported by
